American Society of Clinical Oncology Educational Book

Aims & Scope

The Ed Book is a National Library of Medicine–indexed collection of articles written by ASCO Annual Meeting faculty and invited leaders in oncology.

Ed Book was launched in 1985 to highlight standards of care and inspire future therapeutic possibilities in oncology.

Published annually, each volume highlights the most compelling research and developments across the multidisciplinary fields of oncology and serves as an enduring scholarly resource for all members of the cancer care team long after the Meeting concludes.

These articles address issues in the following areas, among others: Immuno-oncology, Surgical, radiation, and medical oncology, Clinical informatics and quality of care, Global health, Survivorship.

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Medline
• Embase

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology, Medicine and Nursing, designed to support cutting-edge academic discovery.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Mechanisms of Resistance to Immune Checkpoint Blockade: Why Does Checkpoint Inhibitor Immunotherapy Not Work for All Patients?

  Citation: 534

  Authors: Charlene M., Eliezer M., Charles G., James P., Siwen

• The Role of Clinical Trial Participation in Cancer Research: Barriers, Evidence, and Strategies

  Citation: 532

  Authors: Joseph M., Elise, Eric, Archie

• Implementation of Patient-Reported Outcomes in Routine Medical Care

  Citation: 339

  Authors: Ethan, Lisa, Carolyn L., Galina

• Managing Immune Checkpoint-Blocking Antibody Side Effects

  Citation: 311

  Authors: Michael A.

• Telemedicine in Cancer Care

  Citation: 284

  Authors: S. Joseph, Ana Maria

• Patient-Reported Outcomes in Cancer Clinical Trials: Measuring Symptomatic Adverse Events With the National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

  Citation: 270

  Authors: Paul G., Diana T., Ethan M., Sandra A.

• Updated Diagnostic Criteria and Staging System for Multiple Myeloma

  Citation: 250

  Authors: S. Vincent

• The Other Side of CAR T-Cell Therapy: Cytokine Release Syndrome, Neurologic Toxicity, and Financial Burden

  Citation: 247

  Authors: Bianca, Carlos, Jason, Katayoun, Elizabeth J.

• Early Detection of Cancer: Past, Present, and Future

  Citation: 246

  Authors: Joshua D., Paul G., Peter

• Biomarker Testing for Patients With Advanced Non–Small Cell Lung Cancer: Real-World Issues and Tough Choices

  Citation: 239

  Authors: Nathan A., Maria E., David R., Howard